4,4',4'',4'''-([2,2'-Bi(1,3-dithiolylidene)]-4,4',5,5'-tetrayl)tetraaniline, 97%, 1g

Methyl 2-methylquinoline-6-carboxylate, 99.0%, 5g

N-(3-(2,4-Dichlorophenoxy)propyl)-N-methylprop-2-yn-1-amine hydrochloride, 95.0%, 250mg

2,6-Difluoro-4-methoxypyridine, 95.0%, 1g

Methyl 1-amino-2,3-dihydro-1H-indene-4-carboxylate, 98%, 100mg

2-(3,5-Dichlorophenyl)cyclopropane-1-carboxylic acid, 98%, 1g

Gallic acid monohydrate, min. 98%, pa, ACS, 500 g, plastic packaging.

8-chloro-3-iodoquinoline, 95.0%, 25g

Tetrahexylammonium Hydrogen Sulfate>98.0%(T)(N)5g

5-{benzyl[3-(trifluoromethyl)phenyl]sulfamoyl}-2-chlorobenzoic acid, 97%, 250mg

ELESCLOMOL, 95%, 1g

2,2'-Bipyridine-6-carbonitrile>98.0%(GC)200mg

1-Benzyl-3-carbethoxy-4-piperidone hydrochloride, 97.0%, 1g